Literature DB >> 24630991

The Marburg virus VP24 protein interacts with Keap1 to activate the cytoprotective antioxidant response pathway.

Megan R Edwards1, Britney Johnson2, Chad E Mire3, Wei Xu2, Reed S Shabman1, Lauren N Speller2, Daisy W Leung2, Thomas W Geisbert3, Gaya K Amarasinghe2, Christopher F Basler4.   

Abstract

Kelch-like ECH-associated protein 1 (Keap1) is a ubiquitin E3 ligase specificity factor that targets transcription factor nuclear factor (erythroid-derived 2)-like 2 (Nrf2) for ubiquitination and degradation. Disrupting Keap1-Nrf2 interaction stabilizes Nrf2, resulting in Nrf2 nuclear accumulation, binding to antioxidant response elements (AREs), and transcription of cytoprotective genes. Marburg virus (MARV) is a zoonotic pathogen that likely uses bats as reservoir hosts. We demonstrate that MARV protein VP24 (mVP24) binds the Kelch domain of either human or bat Keap1. This binding is of high affinity and 1:1 stoichiometry and activates Nrf2. Modeling based on the Zaire ebolavirus (EBOV) VP24 (eVP24) structure identified in mVP24 an acidic loop (K-loop) critical for Keap1 interaction. Transfer of the K-loop to eVP24, which otherwise does not bind Keap1, confers Keap1 binding and Nrf2 activation, and infection by MARV, but not EBOV, activates ARE gene expression. Therefore, MARV targets Keap1 to activate Nrf2-induced cytoprotective responses during infection.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24630991      PMCID: PMC3985291          DOI: 10.1016/j.celrep.2014.01.043

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  47 in total

1.  PGAM5, a Bcl-XL-interacting protein, is a novel substrate for the redox-regulated Keap1-dependent ubiquitin ligase complex.

Authors:  Shih-Ching Lo; Mark Hannink
Journal:  J Biol Chem       Date:  2006-10-17       Impact factor: 5.157

2.  Protein structure prediction on the Web: a case study using the Phyre server.

Authors:  Lawrence A Kelley; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

3.  Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1.

Authors:  St Patrick Reid; Charalampos Valmas; Osvaldo Martinez; Freddy Mauricio Sanchez; Christopher F Basler
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

4.  Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response.

Authors:  Kit I Tong; Balasundaram Padmanabhan; Akira Kobayashi; Chengwei Shang; Yosuke Hirotsu; Shigeyuki Yokoyama; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2007-09-04       Impact factor: 4.272

5.  Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24.

Authors:  Thomas Hoenen; Allison Groseth; Larissa Kolesnikova; Steven Theriault; Hideki Ebihara; Bettina Hartlieb; Sandra Bamberg; Heinz Feldmann; Ute Ströher; Stephan Becker
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

6.  Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation.

Authors:  St Patrick Reid; Lawrence W Leung; Amy L Hartman; Osvaldo Martinez; Megan L Shaw; Caroline Carbonnelle; Viktor E Volchkov; Stuart T Nichol; Christopher F Basler
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

7.  Ebola virus (EBOV) VP24 inhibits transcription and replication of the EBOV genome.

Authors:  Shinji Watanabe; Takeshi Noda; Peter Halfmann; Luke Jasenosky; Yoshihiro Kawaoka
Journal:  J Infect Dis       Date:  2007-11-15       Impact factor: 5.226

8.  Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus disease.

Authors:  Hye-Youn Cho; Farhad Imani; Laura Miller-DeGraff; Dianne Walters; Guillermina A Melendi; Masayuki Yamamoto; Fernando P Polack; Steven R Kleeberger
Journal:  Am J Respir Crit Care Med       Date:  2008-10-17       Impact factor: 21.405

9.  Structural analysis of the complex of Keap1 with a prothymosin alpha peptide.

Authors:  Balasundaram Padmanabhan; Yoshihiro Nakamura; Shigeyuki Yokoyama
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-03-21

10.  Assembly and budding of Ebolavirus.

Authors:  Takeshi Noda; Hideki Ebihara; Yukiko Muramoto; Ken Fujii; Ayato Takada; Hiroshi Sagara; Jin Hyun Kim; Hiroshi Kida; Heinz Feldmann; Yoshihiro Kawaoka
Journal:  PLoS Pathog       Date:  2006-09       Impact factor: 6.823

View more
  53 in total

1.  Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins.

Authors:  Megan R Edwards; Gai Liu; Chad E Mire; Suhas Sureshchandra; Priya Luthra; Benjamin Yen; Reed S Shabman; Daisy W Leung; Ilhem Messaoudi; Thomas W Geisbert; Gaya K Amarasinghe; Christopher F Basler
Journal:  Cell Rep       Date:  2016-02-11       Impact factor: 9.423

2.  A Sensitive in Vitro High-Throughput Screen To Identify Pan-filoviral Replication Inhibitors Targeting the VP35-NP Interface.

Authors:  Gai Liu; Peter J Nash; Britney Johnson; Colette Pietzsch; Ma Xenia G Ilagan; Alexander Bukreyev; Christopher F Basler; Terry L Bowlin; Donald T Moir; Daisy W Leung; Gaya K Amarasinghe
Journal:  ACS Infect Dis       Date:  2017-02-09       Impact factor: 5.084

3.  Predictive and comparative analysis of Ebolavirus proteins.

Authors:  Qian Cong; Jimin Pei; Nick V Grishin
Journal:  Cell Cycle       Date:  2015-07-09       Impact factor: 4.534

Review 4.  Innate immune evasion by filoviruses.

Authors:  Christopher F Basler
Journal:  Virology       Date:  2015-04-03       Impact factor: 3.616

5.  Severe Fever with Thrombocytopenia Syndrome Virus NSs Interacts with TRIM21 To Activate the p62-Keap1-Nrf2 Pathway.

Authors:  Younho Choi; Zhongyi Jiang; Woo-Jin Shin; Jae U Jung
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

6.  Ebola virus VP24 targets a unique NLS binding site on karyopherin alpha 5 to selectively compete with nuclear import of phosphorylated STAT1.

Authors:  Wei Xu; Megan R Edwards; Dominika M Borek; Alicia R Feagins; Anuradha Mittal; Joshua B Alinger; Kayla N Berry; Benjamin Yen; Jennifer Hamilton; Tom J Brett; Rohit V Pappu; Daisy W Leung; Christopher F Basler; Gaya K Amarasinghe
Journal:  Cell Host Microbe       Date:  2014-08-13       Impact factor: 21.023

Review 7.  The Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases.

Authors:  Prashant Deshmukh; Sruthi Unni; Gopinatha Krishnappa; Balasundaram Padmanabhan
Journal:  Biophys Rev       Date:  2016-12-06

8.  Impact of Měnglà Virus Proteins on Human and Bat Innate Immune Pathways.

Authors:  Caroline G Williams; Joyce Sweeney Gibbons; Timothy R Keiffer; Priya Luthra; Megan R Edwards; Christopher F Basler
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

9.  Antioncogenic and Oncogenic Properties of Nrf2 in Arsenic-induced Carcinogenesis.

Authors:  Young-Ok Son; Poyil Pratheeshkumar; Ram Vinod Roy; John Andrew Hitron; Lei Wang; Sasidharan Padmaja Divya; Mei Xu; Jia Luo; Gang Chen; Zhuo Zhang; Xianglin Shi
Journal:  J Biol Chem       Date:  2015-09-18       Impact factor: 5.157

10.  Dimerization Controls Marburg Virus VP24-dependent Modulation of Host Antioxidative Stress Responses.

Authors:  Britney Johnson; Jing Li; Jagat Adhikari; Megan R Edwards; Hao Zhang; Toni Schwarz; Daisy W Leung; Christopher F Basler; Michael L Gross; Gaya K Amarasinghe
Journal:  J Mol Biol       Date:  2016-08-04       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.